Search

everythinglearnresearchcommunity

for

Search:↓

Compound 4 is a promising treatment for hair loss with low toxicity.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Certain drugs that block specific enzymes can help treat prostate diseases.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

P-3074 effectively blocks scalp DHT better than oral finasteride.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Finasteride is most linked to drug-induced erectile dysfunction.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Pranlukast and mirabegron may work as new diabetes drugs.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

DPP may help hair regrowth by improving blood vessel function under stress.

DPP4-positive fibroblasts play a major role in producing proteins that lead to skin fibrosis.

Using tamsulosin with finasteride is the most effective and reduces surgery risk for BPH.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

A new combination of tadalafil and finasteride improves drug performance and stability.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.